Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Recommendation of “Moderate Buy” from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $27.1111.

Several equities research analysts have issued reports on the stock. Barclays dropped their target price on shares of Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a research report on Friday, November 21st. Benchmark dropped their price objective on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a report on Tuesday, November 11th. Royal Bank Of Canada cut their target price on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. JPMorgan Chase & Co. lowered their price target on Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a research report on Monday, November 24th. Finally, UBS Group dropped their price target on Surgery Partners from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Thursday, November 13th.

Institutional Trading of Surgery Partners

Several hedge funds and other institutional investors have recently bought and sold shares of SGRY. Pentwater Capital Management LP raised its stake in shares of Surgery Partners by 66.9% during the third quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock worth $252,777,000 after acquiring an additional 4,681,000 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Surgery Partners by 5.9% during the 3rd quarter. Vanguard Group Inc. now owns 7,614,514 shares of the company’s stock valued at $164,778,000 after purchasing an additional 424,518 shares during the last quarter. King Street Capital Management L.P. grew its holdings in shares of Surgery Partners by 24.5% during the 2nd quarter. King Street Capital Management L.P. now owns 6,225,000 shares of the company’s stock valued at $138,382,000 after purchasing an additional 1,225,000 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Surgery Partners by 25.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 4,860,215 shares of the company’s stock worth $105,177,000 after purchasing an additional 988,956 shares during the period. Finally, UBS Group AG lifted its stake in Surgery Partners by 50.6% in the third quarter. UBS Group AG now owns 3,690,922 shares of the company’s stock worth $79,872,000 after purchasing an additional 1,239,549 shares during the last quarter.

Surgery Partners Price Performance

NASDAQ:SGRY opened at $15.80 on Friday. Surgery Partners has a 52-week low of $14.94 and a 52-week high of $26.16. The stock has a fifty day moving average of $15.99 and a 200 day moving average of $19.75. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88. The firm has a market capitalization of $2.04 billion, a price-to-earnings ratio of -11.62 and a beta of 1.91.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Monday, November 10th. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). The business had revenue of $821.50 million during the quarter, compared to the consensus estimate of $823.55 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.Surgery Partners’s revenue was up 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.19 earnings per share. On average, research analysts expect that Surgery Partners will post 0.67 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.